Research Funding and Policy Implications in the Further Consolidated Appropriations Act, 2024
The act includes $47.1 billion for the National Institutes of Health (NIH), $378 million (0.8%) below the FY 2023 enacted level.
Read moreOn June 26, The Biden Administration released the Persistent Poverty Initiative, an initiative coordinated by the National Cancer Institute (NCI) that awards $50 million to reduce inequities in the social determinants of health related to cancer and cancer prevention. The goal of the initiative is to alleviate the cumulative effects of persistent poverty on cancer outcomes in parts of the country where, for the past 30 years, 20% or more of the population has lived below the federal poverty line. This will be accomplished by building research capacity, fostering cancer prevention research and promoting the implementation of community-based programs.
Five new Centers for Cancer Control Research in Persistent Poverty Areas are funded through these awards for the next five years. The centers will advance priorities of the Biden Administration's reignited Cancer Moonshot, including the reduction of inequities in the structural drivers of cancer, reducing tobacco use and increasing access to healthy food. The centers, who all work with targeted low-income communities, are:
The American College of Radiology® (ACR®) continues to monitor developments and progress with the Cancer Moonshot initiative, which aims to decrease cancer deaths by more than 50% in the next 25 years.
For more information, contact Katie Grady, ACR Government Affairs Director.
Research Funding and Policy Implications in the Further Consolidated Appropriations Act, 2024
The act includes $47.1 billion for the National Institutes of Health (NIH), $378 million (0.8%) below the FY 2023 enacted level.
Read moreACR Seeks Partners for New ARPA-H Program to Revolutionize Cancer Treatment
ADAPT program awardees will map and target tumor changes that improve survival rates for patients with metastatic cancer.
Read moreRegister Now: Co-Clinical Imaging Research Resource Program Annual Meeting
The National Cancer Institute (NCI) will hold its Co-Clinical Imaging Research Resource Program (CIRP) meeting May 20–21. The meeting, which offers free registration, will focus on how quantitative imaging methods are optimized to improve the quality of imaging results for co-clinical trials of adult and pediatric cancers; what co-clinical quantitative imaging information is currently available at NCI co-clinical imaging research resources; and applications of co-clinical imaging to oncology precision medicine.
Read more